Summit Therapeutics Ownership 2024 | Who Owns Summit Therapeutics Now?
Institutional Ownership
10.21%
Insider Ownership
88.14%
Retail Ownership
1.65%
Institutional Holders
124.00
Summit Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 3.31% | 2.31% | 23,222,222 | 23,222,222 | 100.00% | 181,133,332 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.26% | 0.00% | 8,818,463 | 1,549,220 | 21.31% | 68,784,012 | Jun 30, 2024 |
| BLACKROCK INC. | 1.13% | 0.00% | 7,898,585 | -1,924,756 | -19.59% | 61,608,963 | Jun 30, 2024 |
| FMR LLC | 1.08% | 0.00% | 7,565,427 | -409,104 | -5.13% | 59,010,330 | Jun 30, 2024 |
| STATE STREET CORP | 0.59% | 0.00% | 4,123,137 | -3,991,093 | -49.19% | 32,160,469,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.42% | 0.00% | 2,963,827 | -188,563 | -5.98% | 23,122,403 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.29% | 0.00% | 2,042,100 | 2,008,955 | 6061.11% | 15,930,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.28% | 0.01% | 1,942,858 | 1,942,858 | 100.00% | 15,154,292 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.14% | 0.01% | 1,010,157 | 1,010,157 | 100.00% | 7,879,225 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | 0.00% | 960,303 | -112,411 | -10.48% | 7,490,363,000 | Jun 30, 2024 |
| ANSON FUNDS MANAGEMENT LP | 0.13% | 0.88% | 941,908 | 941,908 | 100.00% | 7,346,882 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.13% | 0.00% | 934,729 | -81,816 | -8.05% | 7,290,886 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.11% | 0.01% | 788,067 | 788,067 | 100.00% | 6,146,922 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.10% | 0.09% | 723,700 | 723,700 | 100.00% | 5,644,860 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.10% | 0.01% | 708,623 | 698,560 | 6941.87% | 5,527,259 | Jun 30, 2024 |
| QVT FINANCIAL LP | 0.08% | 0.42% | 575,705 | 575,705 | 100.00% | 4,490,499 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.08% | 0.01% | 544,877 | -6,892 | -1.25% | 4,250,041,000 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.07% | 0.06% | 499,100 | 499,100 | 100.00% | 3,892,980 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.06% | 0.00% | 453,944 | -226,657 | -33.30% | 3,540,763 | Jun 30, 2024 |
| BARCLAYS PLC | 0.06% | 0.00% | 387,313 | -5,999 | -1.53% | 3,021,000 | Jun 30, 2024 |
Summit Therapeutics's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 3.31% of the company's total share outstanding, currently valued at $181.13M. The top 10 institutional shareholders own together 8.63% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 3.31% | 2.31% | 23,222,222 | 23,222,222 | 100.00% | 181,133,332 | Jun 30, 2024 |
| ANSON FUNDS MANAGEMENT LP | 0.13% | 0.88% | 941,908 | 941,908 | 100.00% | 7,346,882 | Jun 30, 2024 |
| QVT FINANCIAL LP | 0.08% | 0.42% | 575,705 | 575,705 | 100.00% | 4,490,499 | Jun 30, 2024 |
| WEALTH MANAGEMENT PARTNERS, LLC | 0.01% | 0.16% | 42,000 | -2,000 | -4.55% | 327,600 | Jun 30, 2024 |
| PINPOINT ASSET MANAGEMENT LTD | 0.02% | 0.13% | 120,746 | 120,746 | 100.00% | 941,819 | Jun 30, 2024 |
| VANCE WEALTH, INC. | 0.01% | 0.13% | 39,266 | - | - | 306,275 | Jun 30, 2024 |
| SARGENT INVESTMENT GROUP, LLC | 0.01% | 0.11% | 72,000 | 62,000 | 620.00% | 561,600 | Jun 30, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 0.01% | 0.09% | 82,473 | -52,372 | -38.84% | 643,289 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.10% | 0.09% | 723,700 | 723,700 | 100.00% | 5,644,860 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.00% | 0.08% | 25,000 | -290,000 | -92.06% | 195,000 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.07% | 0.06% | 499,100 | 499,100 | 100.00% | 3,892,980 | Jun 30, 2024 |
| FULLCIRCLE WEALTH LLC | 0.00% | 0.06% | 12,209 | 12,209 | 100.00% | 121,846 | Jun 30, 2024 |
| HOYLECOHEN, LLC | 0.01% | 0.05% | 86,408 | 2,000 | 2.37% | 673,983 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.00% | 0.04% | 11,190 | -21,625 | -65.90% | 87,282 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.00% | 0.04% | 29,149 | -5,851 | -16.72% | 227,362 | Jun 30, 2024 |
| LEVIN CAPITAL STRATEGIES, L.P. | 0.01% | 0.03% | 39,176 | - | - | 305,573 | Jun 30, 2024 |
| WORLD EQUITY GROUP, INC. | 0.00% | 0.03% | 12,779 | 153 | 1.21% | 99,676 | Jun 30, 2024 |
| BLANKINSHIP & FOSTER, LLC | 0.00% | 0.03% | 12,777 | - | - | 99,661 | Jun 30, 2024 |
| BENDER ROBERT & ASSOCIATES | 0.00% | 0.02% | 14,059 | 14,059 | 100.00% | 109,660 | Jun 30, 2024 |
| FPC INVESTMENT ADVISORY, INC. | 0.00% | 0.02% | 1,946 | - | - | 18,118 | Jun 30, 2024 |
The largest Summit Therapeutics shareholder by % of total assets is BAKER BROS. ADVISORS LP. The company owns 23.22M shares of Summit Therapeutics (SMMT), representing 2.31% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 3.31% | 2.31% | 23,222,222 | 23,222,222 | 100.00% | 181,133,332 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.29% | 0.00% | 2,042,100 | 2,008,955 | 6061.11% | 15,930,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.28% | 0.01% | 1,942,858 | 1,942,858 | 100.00% | 15,154,292 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.26% | 0.00% | 8,818,463 | 1,549,220 | 21.31% | 68,784,012 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.14% | 0.01% | 1,010,157 | 1,010,157 | 100.00% | 7,879,225 | Jun 30, 2024 |
| ANSON FUNDS MANAGEMENT LP | 0.13% | 0.88% | 941,908 | 941,908 | 100.00% | 7,346,882 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.11% | 0.01% | 788,067 | 788,067 | 100.00% | 6,146,922 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.10% | 0.09% | 723,700 | 723,700 | 100.00% | 5,644,860 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.10% | 0.01% | 708,623 | 698,560 | 6941.87% | 5,527,259 | Jun 30, 2024 |
| QVT FINANCIAL LP | 0.08% | 0.42% | 575,705 | 575,705 | 100.00% | 4,490,499 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.07% | 0.06% | 499,100 | 499,100 | 100.00% | 3,892,980 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.04% | 0.00% | 266,800 | 266,800 | 100.00% | 2,081,040 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.04% | 0.00% | 257,046 | 217,580 | 551.31% | 2,004,959 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.04% | 0.00% | 308,576 | 186,566 | 152.91% | 2,406,893 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.02% | 0.00% | 141,680 | 141,680 | 100.00% | 1,105,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 140,577 | 140,577 | 100.00% | 1,096,501 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.03% | 0.00% | 206,057 | 128,934 | 167.18% | 1,607,245 | Jun 30, 2024 |
| PINPOINT ASSET MANAGEMENT LTD | 0.02% | 0.13% | 120,746 | 120,746 | 100.00% | 941,819 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.02% | 0.00% | 114,647 | 114,647 | 100.00% | 894,000 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.01% | 0.00% | 75,000 | 75,000 | 100.00% | 585,000 | Jun 30, 2024 |
As of Jun 30 2024, Summit Therapeutics's largest institutional buyer is BAKER BROS. ADVISORS LP. The company purchased 23.22M stocks of SMMT, valued at $181.13M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 0.59% | 0.00% | 4,123,137 | -3,991,093 | -49.19% | 32,160,469,000 | Jun 30, 2024 |
| BLACKROCK INC. | 1.13% | 0.00% | 7,898,585 | -1,924,756 | -19.59% | 61,608,963 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | - | - | - | -606,500 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -589,566 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -494,924 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.02% | 0.00% | 165,898 | -484,388 | -74.49% | 1,294,004 | Jun 30, 2024 |
| FMR LLC | 1.08% | 0.00% | 7,565,427 | -409,104 | -5.13% | 59,010,330 | Jun 30, 2024 |
| MORGAN STANLEY | 0.05% | 0.00% | 337,117 | -355,424 | -51.32% | 2,629,512 | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | 0.00% | 167,867 | -309,075 | -64.80% | 1,309,363 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.00% | 0.08% | 25,000 | -290,000 | -92.06% | 195,000 | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -275,000 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.06% | 0.00% | 453,944 | -226,657 | -33.30% | 3,540,763 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.42% | 0.00% | 2,963,827 | -188,563 | -5.98% | 23,122,403 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | 0.00% | 6,343 | -131,303 | -95.39% | 49,475 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -114,592 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | 0.00% | 960,303 | -112,411 | -10.48% | 7,490,363,000 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -102,394 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.04% | 0.00% | 276,692 | -93,233 | -25.20% | 2,158,198 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.00% | - | 28,233 | -89,385 | -76.00% | 220,076 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.02% | 0.00% | 163,750 | -85,917 | -34.41% | 1,277,250 | Jun 30, 2024 |
As of Jun 30 2024, Summit Therapeutics's biggest institutional seller is STATE STREET CORP. The company sold -3.99M shares of SMMT, valued at $32.16B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 3.31% | 2.31% | 23,222,222 | 23,222,222 | 100.00% | 181,133,332 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.28% | 0.01% | 1,942,858 | 1,942,858 | 100.00% | 15,154,292 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.14% | 0.01% | 1,010,157 | 1,010,157 | 100.00% | 7,879,225 | Jun 30, 2024 |
| ANSON FUNDS MANAGEMENT LP | 0.13% | 0.88% | 941,908 | 941,908 | 100.00% | 7,346,882 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.10% | 0.09% | 723,700 | 723,700 | 100.00% | 5,644,860 | Jun 30, 2024 |
| QVT FINANCIAL LP | 0.08% | 0.42% | 575,705 | 575,705 | 100.00% | 4,490,499 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.07% | 0.06% | 499,100 | 499,100 | 100.00% | 3,892,980 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.04% | 0.00% | 266,800 | 266,800 | 100.00% | 2,081,040 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.02% | 0.00% | 141,680 | 141,680 | 100.00% | 1,105,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 140,577 | 140,577 | 100.00% | 1,096,501 | Jun 30, 2024 |
| PINPOINT ASSET MANAGEMENT LTD | 0.02% | 0.13% | 120,746 | 120,746 | 100.00% | 941,819 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.02% | 0.00% | 114,647 | 114,647 | 100.00% | 894,000 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.01% | 0.00% | 75,000 | 75,000 | 100.00% | 585,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.01% | 0.00% | 64,818 | 64,818 | 100.00% | 506,018 | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | 0.01% | 0.00% | 63,900 | 63,900 | 100.00% | 498,000 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 62,114 | 62,114 | 100.00% | 484,490 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.01% | 0.00% | 50,000 | 50,000 | 100.00% | 390,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.01% | 0.00% | 47,097 | 47,097 | 100.00% | 367,357 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.01% | 0.00% | 35,500 | 35,500 | 100.00% | 276,900 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | 0.00% | 0.00% | 32,800 | 32,800 | 100.00% | 255,840 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.00% | 0.00% | 31,214 | 31,214 | 100.00% | 243,469 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.00% | 0.00% | 29,700 | 29,700 | 100.00% | 231,660 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.00% | 0.00% | 29,225 | 29,225 | 100.00% | 227,955 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.00% | 0.01% | 28,400 | 28,400 | 100.00% | 221,520 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 0.00% | 0.00% | 25,000 | 25,000 | 100.00% | 47,499 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.00% | 0.00% | 21,919 | 21,919 | 100.00% | 170,968 | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | 0.00% | 0.00% | 19,953 | 19,953 | 100.00% | 155,633 | Jun 30, 2024 |
| CIBC ASSET MANAGEMENT INC | 0.00% | 0.00% | 19,705 | 19,705 | 100.00% | 153,699 | Jun 30, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | 0.00% | 0.00% | 19,500 | 19,500 | 100.00% | 152,100 | Jun 30, 2024 |
| SVB WEALTH LLC | 0.00% | 0.00% | 17,150 | 17,150 | 100.00% | 133,770 | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.00% | 0.01% | 16,499 | 16,499 | 100.00% | 128,692 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.00% | 0.01% | 15,500 | 15,500 | 100.00% | 120,900 | Jun 30, 2024 |
| BENDER ROBERT & ASSOCIATES | 0.00% | 0.02% | 14,059 | 14,059 | 100.00% | 109,660 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | 0.00% | 0.00% | 12,700 | 12,700 | 100.00% | 99,060 | Jun 30, 2024 |
| FULLCIRCLE WEALTH LLC | 0.00% | 0.06% | 12,209 | 12,209 | 100.00% | 121,846 | Jun 30, 2024 |
| CREATIVEONE WEALTH, LLC | 0.00% | 0.00% | 11,600 | 11,600 | 100.00% | 90,000 | Jun 30, 2024 |
| QUINN OPPORTUNITY PARTNERS LLC | 0.00% | 0.01% | 11,000 | 11,000 | 100.00% | 85,800 | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | 0.00% | 0.00% | 10,580 | 10,580 | 100.00% | 82,524 | Jun 30, 2024 |
| CSS LLC/IL | 0.00% | 0.00% | 2,000 | 2,000 | 100.00% | 15,600 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 1,274 | 1,274 | 100.00% | 9,937 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 1,019 | 1,019 | 100.00% | 7,949 | Jun 30, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.00% | - | 471 | 471 | 100.00% | 3,674 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | 45 | 45 | 100.00% | 351 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | 22 | 22 | 100.00% | 194 | Jun 30, 2024 |
Summit Therapeutics's largest new institutional shareholder by number of shares is BAKER BROS. ADVISORS LP, purchased 23.22M shares, valued at $181.13M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | - | - | - | -606,500 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -589,566 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -494,924 | -100.00% | - | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -275,000 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -114,592 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -102,394 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -76,590 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -57,108 | -100.00% | - | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | - | - | - | -38,522 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -35,000 | -100.00% | - | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | - | - | - | -31,203 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -30,019 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -27,080 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -24,186 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -23,579 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -22,462 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -20,372 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -18,961 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -6,561 | -100.00% | - | Jun 30, 2024 |
Summit Therapeutics's largest sold out institutional shareholder by shares sold is STEWARD PARTNERS INVESTMENT ADVISORY, LLC, sold -0.61M shares, valued at -, as of undefined.
Summit Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.15% | 77,925 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.15% | 3,275 | -353 | -9.73% | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.08% | 5,354,329 | 5,354,329 | - | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.08% | 241,320 | 3,937 | 1.66% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.05% | 140,000 | 140,000 | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.05% | 574,673 | 81,845 | 16.61% | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.04% | 165,119 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 206,165 | -11,082 | -5.10% | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 76,500 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 18,036 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.03% | 537,522 | 537,522 | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.03% | 742,100 | 742,100 | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.02% | 167,317 | 167,317 | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.02% | 31,085 | -19,629 | -38.71% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 5,550,122 | -1,778,584 | -24.27% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.01% | 77,616 | 77,616 | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 311,328 | 258 | 0.08% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,524,424 | 53,219 | 3.62% | Feb 29, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 280,000 | 280,000 | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 998 | -9,165 | -90.18% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 11,619 | 2,050 | 21.42% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 88,210 | 14,138 | 19.09% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 71,567 | -1,140 | -1.57% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 68,000 | 68,000 | - | Mar 31, 2024 |
| ProFunds | 0.00% | 33,914 | 32,939 | 3378.36% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 70,842 | -5,088 | -6.70% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 474,706 | 474,706 | - | Feb 29, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 7,355 | 7,355 | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 39,466 | -8,567 | -17.84% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 669,142 | 30,960 | 4.85% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 5,177 | -1,511 | -22.59% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 9,433 | 9,433 | - | Mar 28, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 7,738 | -4,880 | -38.67% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 76,770 | 40,147 | 109.62% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,773 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 3,379 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 40,100 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 160,549 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 51,840 | 361 | 0.70% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,226 | 471 | 6.97% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 4,936,987 | -339,583 | -6.44% | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 23,240 | 23,240 | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 115,358 | 29,262 | 33.99% | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 69,342 | 9,875 | 16.61% | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 17,333 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 534,423 | 66,338 | 14.17% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,058 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 293,149 | -11,919 | -3.91% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 7,383 | - | - | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 31,682 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 44,470 | -180 | -0.40% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 20,100 | 771 | 3.99% | Jan 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 69,794 | 69,794 | - | Jan 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 5,417,848 | 5,417,848 | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 3,800 | -600 | -13.64% | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 524 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 17,218 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 320,060 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 19,411 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 18,988 | 6,813 | 55.96% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 69 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 57,751 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 12,267 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 40,272 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 98,100 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 3,907 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 8,399 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 13,128 | -53 | -0.40% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 2,119 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 157 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 53,987 | -399 | -0.73% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 57,452 | 7,092 | 14.08% | Mar 31, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 3,313 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 37,162 | -473 | -1.26% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 22,179 | 1,559 | 7.56% | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 21,835 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 14,196 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 14,548 | 2,464 | 20.39% | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,319 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 30,800 | 26,000 | 541.67% | Feb 29, 2024 |
Summit Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 77.92K shares, compromising 0.15% of its total assets.
Summit Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 124 | 16.98% |
| 31 Mar, 24 | 106 | 9.28% |
| 31 Dec, 23 | 97 | 3.19% |
| 30 Sep, 23 | 94 | -7.84% |
| 30 Jun, 23 | 102 | 3.03% |
| 31 Mar, 23 | 99 | 59.68% |
| 31 Dec, 22 | 62 | 55.00% |
| 30 Sep, 22 | 40 | 14.29% |
| 30 Jun, 22 | 35 | -23.91% |
| 31 Mar, 22 | 46 | -14.81% |
| 31 Dec, 21 | 54 | - |
| 30 Sep, 21 | 54 | -6.90% |
| 30 Jun, 21 | 58 | 56.76% |
| 31 Mar, 21 | 37 | 15.63% |
| 31 Dec, 20 | 32 | 100.00% |
| 30 Sep, 20 | 16 | - |
As of 30 Jun 24, 124 institutions are holding Summit Therapeutics's shares, representing an increase of 16.98% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 71,635,995 | 44.31% |
| 31 Mar, 24 | 49,642,039 | 54.58% |
| 31 Dec, 23 | 32,113,817 | -0.21% |
| 30 Sep, 23 | 32,181,292 | -7.57% |
| 30 Jun, 23 | 34,817,566 | 65.75% |
| 31 Mar, 23 | 21,005,698 | 160.56% |
| 31 Dec, 22 | 8,061,878 | 153.75% |
| 30 Sep, 22 | 3,177,060 | -62.44% |
| 30 Jun, 22 | 8,459,429 | -23.11% |
| 31 Mar, 22 | 11,002,695 | -0.88% |
| 31 Dec, 21 | 11,100,585 | 0.83% |
| 30 Sep, 21 | 11,009,449 | -0.63% |
| 30 Jun, 21 | 11,079,088 | 19.35% |
| 31 Mar, 21 | 9,283,220 | 2.44% |
| 31 Dec, 20 | 9,062,391 | 16.94% |
| 30 Sep, 20 | 7,749,622 | - |
Summit Therapeutics (SMMT) has 71.64M shares outstanding as of 30 Jun 24, up 44.31% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 10.21% | 15.90% |
| 31 Mar, 24 | 8.01% | 37.82% |
| 31 Dec, 23 | 4.60% | 21.63% |
| 30 Sep, 23 | 4.61% | 5.44% |
| 30 Jun, 23 | 9.21% | 29.84% |
| 31 Mar, 23 | 5.55% | 31.95% |
| 31 Dec, 22 | 4.17% | 91.20% |
| 30 Sep, 22 | 2.14% | 2.97% |
| 30 Jun, 22 | 8.49% | 6.74% |
| 31 Mar, 22 | 11.22% | 8.53% |
| 31 Dec, 21 | 11.47% | 8.99% |
| 30 Sep, 21 | 11.30% | 7.56% |
| 30 Jun, 21 | 12.22% | 9.73% |
| 31 Mar, 21 | 11.21% | 6.60% |
| 31 Dec, 20 | 13.03% | 10.06% |
| 30 Sep, 20 | 11.38% | - |
As of 30 Jun 24, Summit Therapeutics is held by 10.21% institutional shareholders, representing a 15.90% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 60 | 3.45% |
| 31 Mar, 24 | 58 | 28.89% |
| 31 Dec, 23 | 45 | 7.14% |
| 30 Sep, 23 | 42 | -28.81% |
| 30 Jun, 23 | 59 | -7.81% |
| 31 Mar, 23 | 64 | 52.38% |
| 31 Dec, 22 | 42 | 68.00% |
| 30 Sep, 22 | 25 | 56.25% |
| 30 Jun, 22 | 16 | -11.11% |
| 31 Mar, 22 | 18 | -18.18% |
| 31 Dec, 21 | 22 | -31.25% |
| 30 Sep, 21 | 32 | -23.81% |
| 30 Jun, 21 | 42 | 82.61% |
| 31 Mar, 21 | 23 | -11.54% |
| 31 Dec, 20 | 26 | 62.50% |
| 30 Sep, 20 | 16 | - |
60 institutional shareholders have increased their position in SMMT stock as of 30 Jun 24 compared to 58 in the previous quarter (a 3.45% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 45 | 73.08% |
| 31 Mar, 24 | 26 | 36.84% |
| 31 Dec, 23 | 19 | - |
| 30 Sep, 23 | 19 | -9.52% |
| 30 Jun, 23 | 21 | 50.00% |
| 31 Mar, 23 | 14 | 100.00% |
| 31 Dec, 22 | 7 | 40.00% |
| 30 Sep, 22 | 5 | -64.29% |
| 30 Jun, 22 | 14 | -17.65% |
| 31 Mar, 22 | 17 | -15.00% |
| 31 Dec, 21 | 20 | 53.85% |
| 30 Sep, 21 | 13 | 30.00% |
| 30 Jun, 21 | 10 | 42.86% |
| 31 Mar, 21 | 7 | 133.33% |
| 31 Dec, 20 | 3 | - |
| 30 Sep, 20 | - | - |
45 institutional shareholders have reduced their position in SMMT stock as of 30 Jun 24 compared to 26 in the previous quarter (a 73.08% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 124 | 16.98% | 71,635,995 | 44.31% | 10.21% | 15.90% | 60 | 3.45% | 45 | 73.08% |
| 31 Mar, 24 | 106 | 9.28% | 49,642,039 | 54.58% | 8.01% | 37.82% | 58 | 28.89% | 26 | 36.84% |
| 31 Dec, 23 | 97 | 3.19% | 32,113,817 | -0.21% | 4.60% | 21.63% | 45 | 7.14% | 19 | - |
| 30 Sep, 23 | 94 | -7.84% | 32,181,292 | -7.57% | 4.61% | 5.44% | 42 | -28.81% | 19 | -9.52% |
| 30 Jun, 23 | 102 | 3.03% | 34,817,566 | 65.75% | 9.21% | 29.84% | 59 | -7.81% | 21 | 50.00% |
| 31 Mar, 23 | 99 | 59.68% | 21,005,698 | 160.56% | 5.55% | 31.95% | 64 | 52.38% | 14 | 100.00% |
| 31 Dec, 22 | 62 | 55.00% | 8,061,878 | 153.75% | 4.17% | 91.20% | 42 | 68.00% | 7 | 40.00% |
| 30 Sep, 22 | 40 | 14.29% | 3,177,060 | -62.44% | 2.14% | 2.97% | 25 | 56.25% | 5 | -64.29% |
| 30 Jun, 22 | 35 | -23.91% | 8,459,429 | -23.11% | 8.49% | 6.74% | 16 | -11.11% | 14 | -17.65% |
| 31 Mar, 22 | 46 | -14.81% | 11,002,695 | -0.88% | 11.22% | 8.53% | 18 | -18.18% | 17 | -15.00% |
| 31 Dec, 21 | 54 | - | 11,100,585 | 0.83% | 11.47% | 8.99% | 22 | -31.25% | 20 | 53.85% |
| 30 Sep, 21 | 54 | -6.90% | 11,009,449 | -0.63% | 11.30% | 7.56% | 32 | -23.81% | 13 | 30.00% |
| 30 Jun, 21 | 58 | 56.76% | 11,079,088 | 19.35% | 12.22% | 9.73% | 42 | 82.61% | 10 | 42.86% |
| 31 Mar, 21 | 37 | 15.63% | 9,283,220 | 2.44% | 11.21% | 6.60% | 23 | -11.54% | 7 | 133.33% |
| 31 Dec, 20 | 32 | 100.00% | 9,062,391 | 16.94% | 13.03% | 10.06% | 26 | 62.50% | 3 | - |
| 30 Sep, 20 | 16 | - | 7,749,622 | - | 11.38% | - | 16 | - | - | - |
Summit Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Summit Therapeutics's stock was made by Anand Bhaskar on Apr 04 2024, selling - shares at - per share (valued at -). The last insider buy of SMMT was made by Zanganeh Mahkam on Mar 27 2024, buying 34,321 shares at $3.72 per share (worth $127.67K).
Summit Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 6 | 1 | 600.00% |
| Q1 2024 | 16 | - | - |
| Q4 2023 | 8 | 2 | 400.00% |
| Q1 2023 | 16 | - | - |
| Q4 2022 | 4 | - | - |
| Q3 2022 | 9 | - | - |
| Q2 2022 | 3 | 2 | 150.00% |
| Q1 2022 | 8 | - | - |
| Q4 2021 | 9 | 1 | 900.00% |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 6 | 1 | 600.00% |
| Q4 2020 | 12 | 11 | 109.09% |
| Q3 2020 | - | 17 | - |
| Q2 2020 | - | 2 | - |
6 total buy trades, and 1 total sell trades (buy/sell ratio of 6.00%) were made by Summit Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | 5 | - | - |
| Q4 2023 | 4 | - | - |
| Q1 2023 | 7 | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | 7 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 1 | 5 | 20.00% |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Summit Therapeutics's stocks.
Summit Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| PHIO | Phio Pharmaceuticals Corp. |
| KRON | Kronos Bio, Inc. |
| NKTX | Nkarta, Inc. |
| OCEA | Ocean Biomedical, Inc. |
| SONN | Sonnet BioTherapeutics Holdings, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| ZURA | Zura Bio Limited |
| ELEV | Elevation Oncology, Inc. |
| CDIO | Cardio Diagnostics Holdings, Inc. |
| ATNF | 180 Life Sciences Corp. |
SMMT Ownership FAQ
Who Owns Summit Therapeutics?
Summit Therapeutics is owned by institutional shareholders (10.21%), insiders (88.14%), and public (1.65%). The largest institutional shareholder of Summit Therapeutics is BAKER BROS. ADVISORS LP (3.31% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.15% of total shares).
Who are the major institutional shareholders of Summit Therapeutics?
Summit Therapeutics's major institutional shareholders are BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BLACKROCK INC., FMR LLC, and STATE STREET CORP. The top five shareholders own together 7.36% of the company's share outstanding.
How many Summit Therapeutics shareholders are there?
As of Jun 2024, there are 124 institutional shareholders of Summit Therapeutics.
What percentage of Summit Therapeutics is owned by BAKER BROS. ADVISORS LP?
BAKER BROS. ADVISORS LP owns 23.22M shares of Summit Therapeutics, representing 3.31% of the company's total shares outstanding, valued at $181.13M (as of Jun 2024).
What percentage of Summit Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 8.82M shares of Summit Therapeutics (SMMT), compromising 1.26% of the company, valued at $68.78M.
What percentage of Summit Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Summit Therapeutics. The company owns 7.9M of the company's shares outstanding (worth $61.61M).